共 50 条
- [36] EGFR mutation positive stage IV non-small-cell lung cancer: treatment beyond progression [J]. FRONTIERS IN ONCOLOGY, 2014, 4
- [38] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors [J]. Oncogene, 2009, 28 : S24 - S31
- [40] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611